Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis

Mayo Clinic Proceedings

Volumn 89, Issue 4, 2014, Pages 484-492

  Parikh, Sameer A ^a   Kapoor, Prashant ^a   Letendre, Louis ^a   Kumar, Shaji ^a   Wolanskyj, Alexandra P ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CAUSAL ATTRIBUTION; CAUSE OF DEATH; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEMOPHAGOCYTIC SYNDROME; HUMAN; HYPOALBUMINEMIA; IDIOPATHIC DISEASE; IMMUNE RESPONSE; INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS; SURVIVAL TIME; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAUSE OF DEATH; COHORT STUDIES; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MIDDLE AGED; ONCOGENE PROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RARE DISEASES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84898886282     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2013.12.012     Document Type: Article

References (60)

1. Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med. 2012;63:233-246.
2. Farquhar JW, Claireaux AE. Familial haemophagocytic reticulosis. Arch Dis Child. 1952;27(136):519-525.
3. Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011;118(15):4041-4052.
4. Feldmann J, Callebaut I, Raposo G, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003;115(4): 461-473.
5. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286(5446):1957- 1959.
6. zur Stadt U, Rohr J, Seifert W, et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin Am J Hum Genet. 2009;85(4):482-492
7. zur Stadt U, Schmidt S, Kasper B, et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin Hum Mol Genet. 2005;14(6):827-834
8. Weitzman S. Approach to hemophagocytic syndromes. Hematology Am Soc Hematol Educ Program. 2011;2011:178-183.
9. Trottestam H, Horne A, Arico M, et al. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood. 2011;118(17):4577-4584.
10. ClinicalTrials.gov. Treatment Protocol for Hemophagocytic Lymphohistiocytosis. http://www.clinicaltrials.gov/ct2/show/NCT0042 6101?term=Treatment+Protocol+for+Hemophagocytic+ Lymphohistiocytosis&rank=1. Accessed November 17, 2013.
11. ShabbirM, Lucas J, Lazarchick J, Shirai K. Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literature. Hematol Oncol. 2011;29(2):100-106.
12. Takahashi N, Chubachi A, Kume M, et al. A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases. Int J Hematol. 2001;74(2):209-213.
13. Bodio KA, Campo M, Arnason JE. Hemophagocytic lymphohistiocytosis: truly on the rise or simply on the radar? ASH Annual Meeting Abstracts. 2012;120(21):2151.
14. Buckley SA, Egan D, Walter RB. Hemophagocytic lymphohistiocytosis in adults: a case series of 30 patients at a U.S. tertiary care center. ASH Annual Meeting Abstracts. 2012;120(21):4681.
15. Schenk T, Maschmeyer G, Rothmann F, et al. Adult patients with hemophagocytic lymphohistiocytosis (HLH) in Germany: a retrospective multicenter case study of 29 patients. ASH Annual Meeting Abstracts. 2012;120(21):3271.
16. Tseng YT, Sheng WH, Lin BH, et al. Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults. J Microbiol Immunol Infect. 2011;44(3):191-197.
17. Machaczka M, Vaktnas J, Klimkowska M, Hagglund H. Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center. Leukemia Lymphoma. 2011;52(4):613-619.
18. Blom A, Beylot-Barry M, D'Incan M, Laroche L. Lymphomaassociated hemophagocytic syndrome (LAHS) in advancedstage mycosis fungoides/Sezary syndrome cutaneous T-cell lymphoma. J Am Acad Dermatol. 2011;65(2):404-410.
19. Han AR, Lee HR, Park BB, et al. Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome. Ann Hematol. 2007;86(7):493-498.
20. Takahashi N, Miura I, Chubachi A, Miura AB, Nakamura S. A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma. Int J Hematol. 2001;74(3):303-308.
21. Tong H, Ren Y, Liu H, et al. Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: comparison of T-cell lymphoma with and without hemophagocytic syndrome. Leukemia Lymphoma. 2008;49(1):81-87.
22. Allory Y, Challine D, Haioun C, et al. Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation: a clinicopathologic study of 11 patients in a Western institution. Am J Surg Pathol. 2001;25(7):865-874.
23. Lambotte O, Khellaf M, Harmouche H, et al. Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome. Medicine. 2006;85(3):169-182.
24. Fukaya S, Yasuda S, Hashimoto T, et al. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology. 2008;47(11):1686-1691.
25. Dhote R, Simon J, Papo T, et al. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum. 2003;49(5):633-639.
26. Park HS, Kim DY, Lee JH, et al. Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors. Ann Hematol. 2012;91(6):897-904.
27. Henter JI, Horne A, Arico M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124-131.
28. Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program. 2009:523-531.
29. Asai N, Ohkuni Y, Matsunuma R, et al. A case of novel swine influenza A (H1N1) pneumonia complicated with virusassociated hemophagocytic syndrome. J Infect Chemother. 2012;18(5):771-774.
30. Krishna R, Byrne E, Burbridge J, Salooja N, Naresh KN. The Hammersmith hospital hematopathology case of the month: hemophagocytic lymphohistiocytosis secondary to Epstein-Barr virus associated T-cell lymphoma. Leukemia Lymphoma. 2011;52(6):1127-1132.
31. Munoz J, Shareef N, Donthireddy V. Cytomegalovirus-induced haemophagocytic lymphohistiocytosis syndrome. BMJ Case Rep. 2012;2012.
32. Tan LH, LumLC,Omar SF, Kan FK. Hemophagocytosis in dengue: comprehensive report of six cases. J Clin Virol. 2012;55(1):79-82.
33. Tierney LM Jr, Thabet A, Nishino H. Case records of the Massachusetts General Hospital. Case 10-2011: a woman with fever, confusion, liver failure, anemia, and thrombocytopenia. N Engl J Med. 2011;364(13):1259-1270.
34. Uttenthal BJ, Layton DM, Vyse TJ, Schreiber BE. The wolf at the door. N Engl J Med. 2012;366(23):2216-2221.
35. Miura S, Takeda K, Muto Y, et al. Repeated Epstein-Barr virusassociated hemophagocytic syndrome in a lupus nephritis patient. Clin Nephrol. 2012;77(1):71-74.
36. Koubaa M, Maaloul I, Marrakchi C, et al. Hemophagocytic syndrome associated with visceral leishmaniasis in an immunocompetent adult-case report and review of the literature. Anns Hematol. 2012;91(7):1143-1145.
37. Salado CT, Gallego AG, Carnerero EL, et al. Hemophagocytic lymphohistiocytosis in Crohn's disease associated with primary infection by Epstein-Barr virus. Inflamm Bowel Dis. 2011;17(11): E143-E144.
38. Meki A, O'Connor D, Roberts C, Murray J. Hemophagocytic lymphohistiocytosis in chronic lymphocytic leukemia. J Clin Oncol. 2011;29(24):e685-e687.
39. Ishii E,Ohga S, Imashuku S, et al.Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007;86(1):58-65.
40. Cheng AL, Su IJ, Chen YC, Uen WC, Wang CH. Characteristic clinicopathologic features of Epstein-Barr virusassociated peripheral T-cell lymphoma. Cancer. 1993; 72(3):909-916.
41. Miyahara M, Sano M, Shibata K, et al. B-cell lymphomaassociated hemophagocytic syndrome: clinicopathological characteristics. Ann Hematol. 2000;79(7):378-388.
42. Majluf-Cruz A, Sosa-Camas R, Perez-Ramirez O, Rosas-Cabral A, Vargas-Vorackova F, Labardini-Mendez J. Hemophagocytic syndrome associated with hematological neoplasias. Leuk Res. 1998;22(10):893-898.
43. Falini B, Pileri S, De Solas I, et al. Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood. 1990;75(2): 434-444.
44. Yu JT, Wang CY, Yang Y, et al. Lymphoma-associated hemophagocytic lymphohistiocytosis: experience in adults from a single institution. Ann Hematol. 2013;92:1529-1536.
45. Maakaroun NR, Moanna A, Jacob JT, Albrecht H. Viral infections associated with haemophagocytic syndrome. Rev Med Virol. 2010;20(2):93-105.
46. Tseng YT, Sheng WH, Lin BH, et al. Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults. J Microbiol Immunol Infect. 2011;44(3):191-197.
47. Imashuku S, Kuriyama K, Sakai R, et al. Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH studyl center. Med Pediatr Oncol. 2003;41(2):103-109.
48. Imashuku S, Kuriyama K, Teramura T, et al. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol. 2001; 19(10):2665-2673.
49. Larroche C. Hemophagocytic lymphohistiocytosis in adults: diagnosis and treatment. Joint Bone Spine. 2012;79(4):356-361.
50. Allen CE, Yu X, Kozinetz CA, McClain KL. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2008;50(6):1227-1235.
51. Ma AD, Fedoriw YD, Roehrs P. Hyperferritinemia and hemophagocytic lymphohistiocytosis. single institution experience in adult and pediatric patients. ASH Annual Meeting Abstracts. 2012;120(21):2135.
52. Marsh RA, Allen CE, McClain KL, et al. Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab. Pediatr Blood Cancer. 2013;60(1):101-109.
53. Henzan T, Nagafuji K, Tsukamoto H, et al. Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis. Am J Hematol. 2006;81(1):59-61.
54. Olin RL, Nichols KE, Naghashpour M, et al. Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis. Am J Hematol. 2008; 83(9):747-749.
55. Bruck N, Suttorp M, Kabus M, Heubner G, Gahr M, Pessler F. Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids. J Clin Rheumatol. 2011;17(1):23-27.
56. Rohr J, Beutel K, Maul-Pavicic A, et al. Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases. Haematologica. 2010;95(12):2080-2087.
57. Zhang K, Jordan MB, Marsh RA, et al. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adultonset familial HLH. Blood. 2011;118(22):5794-5798.
58. Sieni E, Cetica V, Piccin A, et al. Familial hemophagocytic lymphohistiocytosis may present during adulthood: clinical and genetic features of a small series. PLoS One. 2012;7(9):e44649.
59. Salzer E, Daschkey S, Choo S, et al. Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27. Haematologica. 2013;98(3):473-478.
60. Bryceson YT, Pende D, Maul-Pavicic A, et al. A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes. Blood. 2012;119(12):2754-2763.